Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of Faecalibacterium bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial
Michael R. Laffin, Hamid Tayebi Khosroshahi, Heekuk Park, L. Laffin +5 more
2019Hemodialysis international. International Symposium on Home Hemodialysis91 citations
Semantic Scholar

